ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Indonesia teams with China's Sinovac for COVID vaccine

Pandemic underscores need for national self-reliance in drug R&D and production

The world's fourth-most populous country is seeking to be self-reliant in pharmaceuticals.   © Reuters

JAKARTA -- The coronavirus pandemic has energized Indonesia's drive for self-reliance in pharmaceuticals, with state-owned Bio Farma collaborating on a vaccine with China's Sinovac Biotech and a company from the United Arab Emirates.

The state-owned Indonesian company considers the tie-ups as important for future development and production of vaccines -- and even new medicines -- in the world's fourth-most populous country.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more